Cardiff Oncology, Inc.
NASDAQ:CRDFBiotechnology
Healthcare
$0.84 +2.12%
+$0.03 today
- Market cap
- $65.27M
- Beta
- 1.38
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$0.65
52W Low $1.16High $4.56
Volume 0.86M
Average 1.05M
Price history
Cardiff Oncology, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-58.05%
Period high
$3.21
Period low
$0.73
Latest
$0.84
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Nov 12, 2026 | Nov 12, 2026 | |
| 8-K | Oct 27, 2026 | Oct 27, 2026 | |
| 3 | Oct 27, 2026 | Oct 27, 2026 | |
| 8-K | Oct 22, 2026 | Oct 22, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| DEFA14A | Aug 26, 2026 | Aug 26, 2026 | |
| DEF 14A | Aug 26, 2026 | Aug 26, 2026 | |
| PRE 14A | Aug 14, 2026 | Aug 14, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| SC 13G/A | Jul 27, 2026 | Jul 27, 2026 | |
| S-8 | Jul 21, 2026 | Jul 21, 2026 | |
| 4 | Jul 16, 2026 | Jul 16, 2026 | |
| 424B5 | Jul 16, 2026 | Jul 16, 2026 |
Competitors
Who does Cardiff Oncology, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CRDF's filings, answered from its disclosures.
What is the latest CRDF filing?
The latest filing shown is 10-Q dated Nov 12, 2026.
How many recent filings does CRDF have?
Intrinsic Alpha currently shows 20 recent filings for CRDF.
Continue the stock analysis
Jump to another research area for this company.